Mersana Therapeutics
MRSN
MRSN
76 hedge funds and large institutions have $60.8M invested in Mersana Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
62% less capital invested
Capital invested by funds: $162M → $60.8M (-$101M)
Holders
76
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.44M | |
| 2 | +$791K | |
| 3 | +$358K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$300K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$291K |
Top Sellers
| 1 | -$5.64M | |
| 2 | -$3.24M | |
| 3 | -$637K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$529K |
| 5 |
SIM
Spark Investment Management
New York
|
-$433K |